Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Netherlands

- PMLiVE

Investments show UK biotech still booming despite Brexit

UK raised a quarter of all European biotech funds

- PMLiVE

Novartis and Syncona back new Swiss biotech Anaveon

Founders focused on IL-2 Receptor Agonists

- PMLiVE

Ex-Pharmacyclics CEO invests $25m in Summit

After Duchenne drug failure, UK biotech looks to new anti-infective

- PMLiVE

In conversation with Pfizer’s Erik Nordkamp

Pfizer’s UK managing director and newly appointed ABPI President talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe

- PMLiVE

New leader at Medivir after setbacks

Christine Lind departs Swedish biotech

- PMLiVE

Orchard plans IPO as gene therapy pipeline advances

UK biotech seeks funds for expanded rare disease portfolio

- PMLiVE

Abingworth raises $315m to expand hunt for promising biotechs

New fund earmarked for early to late-stage European and US firms

- PMLiVE

Sanofi’s rare blood disorder drug Cablivi set for European approval

Rare disease drug among notable CHMP recommendations

- PMLiVE

Daily Brief: Charity criticises NHSE and Vertex over Orkambi access, Sema scores again, NodThera launched

The latest from pharma, biotech and healthcare

- PMLiVE

Paris biocluster appoints Stéphane Roques as new chief

Former general manager for Emmanuel Macron's party to spearhead Paris' bid to attract life sciences investment

- PMLiVE

Daily Brief: EULAR kicks off, Brexit lurches closer and Autolus prepares for IPO

A rapid round up of today's pharma, biotech and healthcare news

- PMLiVE

Jim Mellon’s biotech Juvenescence raises $50m for anti-ageing therapies

Billionaire's belief in emerging anti-ageing therapies fuels start up

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links